Graphene quantum dots target Parkinson's protein

A multinational research team led by Professor Małgorzata Kujawska at the University of Arkansas for Medical Sciences has discovered that Graphene quantum dots, nanoscale carbon particles, can interfere with the aggregation of misfolded proteins linked to neurodegenerative diseases such as Parkinson s disease and Multiple system atrophy. The study, published in Science and Technology of Advanced Materials, demonstrated that Graphene quantum dots significantly reduced toxic protein aggregates in animal models and activated autophagy, a cellular recycling process. While clinical use is still distant, these findings offer a promising new direction for therapeutic strategies against these debilitating conditions, despite challenges like preventing Graphene quantum dots from clumping in liquid suspensions.